BMJ Paediatrics Open (Jul 2021)

Hybrid type 1 effectiveness/implementation trial of the international Guide for Monitoring Child Development: protocol for a cluster-randomised controlled trial

  • Maria del Pilar Grazioso,
  • Peter Rohloff,
  • Ann C Miller,
  • Subodh Gupta,
  • Bradley H Wagenaar,
  • Anita Chary,
  • Chunling Lu,
  • Revan Mustafayev,
  • Chetna Maliye,
  • Abhishek Raut,
  • Roopa Srinivasan,
  • Ilgi Ertem,
  • Vibha Krishnamurthy

DOI
https://doi.org/10.1136/bmjpo-2021-001254
Journal volume & issue
Vol. 5, no. 1

Abstract

Read online

Introduction More than 40% of children under 5 years of age in low-income and middle-income countries are at risk of not reaching their developmental potential. The international Guide for Monitoring Child Development (GMCD) early intervention package is a comprehensive programme to address developmental difficulties using an individualised intervention plan for young children and their families. We will conduct a hybrid type 1 effectiveness–implementation evaluation of the GMCD intervention in rural India and Guatemala.Methods and analysis Using a cluster-randomised design, 624 children aged 0–24 months in 52 clusters (26 in India, 26 in Guatemala) will be assigned to usual care or the GMCD intervention plus usual care delivered by frontline workers for 12 months. After 12 months, the usual care arm will cross over to the intervention, which will continue for 12 additional months (24 total). The intervention will be delivered using a digital mobile device interface. Effectiveness will be assessed for developmental functioning (Bayley Scales of Infant Development, 3rd edition) and nurturing care (Home Observation for Measurement of the Environment Scale) outcomes. Implementation will be assessed using the Reach, Effectiveness, Adoption, Implementation, Maintenance framework. Explanatory qualitative analysis guided by the Consolidated Framework for Implementation Research will explore determinants between clusters with high versus low implementation effectiveness.Ethics and dissemination The study has been approved by the Institutional Review Boards of Brigham and Women’s Hospital, Mahatma Gandhi Institute of Medical Sciences and Maya Health Alliance; and by the Indian Council of Medical Research/Health Ministry Screening Committee. Key study findings will be published in international open-access journals.Trial registration number NCT04665297, CTRI/2020/12/029748.Protocol version 1.0 (12 November 2020).